Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand+ tumor cells in B chronic lymphocytic leukemia

Blood

Volumn 91, Issue 11, 1998, Pages 4273-4281

  Tinhofer, Inge ^a   Marschitz, Ingrid ^a   Kos, Marion ^a   Henn, Traudl ^a   Egle, Alexander ^a   Villunger, Andreas ^a   Greil, Richard ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; CANCER INHIBITION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOREGULATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; T CELL LEUKEMIA;

EID: 0032101593     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.11.4273.411k25_4273_4281     Document Type: Article

References (42)

1. Cheson BD, Bennett JM, Rai KR, Grever MR, Kay NE, Schiffer CA, Oken MM, Keating MJ, Boldt DH, Kempin SJ, Foon KA: Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the National Cancer Institute-sponsored working group. Am J Hematol 29:152, 1988
2. Herrmann F, Lochner A, Philippen H, Jauer B, Ruehl H: Imbalance of T-cell subpopulations in patients with chronic leukemia of the B cell type. Clin Exp Immunol 49:157, 1982
3. Platsoucas CD, Galinski M, Kempin S, Reich L, Clarkson B, Good RA: Abnormal T-lymphocyte subpopulations in patients with B cell chronic lymphocytic leukemia: An analysis by monoclonal antibody. J Immunol 129:2305, 1982
4. Kay NE: Abnormal T-cell subpopulation function in CLL: Excessive suppressor and deficient helper (T) activity with respect to B-cell proliferation. Blood 57:418, 1981
5. Chiorazzi N, Fu SM, Montazeri G, Kunkel HG, Rai K, Gee T: T-cell helper defect in patients with chronic lymphocytic leukemia. J Immunol 122:1087, 1979
6. Peller S, Kaufman S: Decreased CD45RA T-cells in B-cell chronic lymphatic leukemia patients: Correlation with disease stage. Blood 78:1569, 1991
7. Tötterman TH, Carlsson M, Simonsson B, Bengtsson M, Nilsson K: T-cell activation and subset patterns are altered in B-CLL and correlate with the stage of the disease. Blood 74:786, 1989
8. + lymphocyte depletion and human immunodeficiency virus replication. Blood 89:1357, 1997
9. + T-cells from human immunodeficiency virus-infected persons: Differential in vitro preventive effect of cytokines and protease antagonists. Blood 87:4959, 1996
10. + T-cells from HIV-infected patients increases with disease progression. J Mol Med 73:591, 1995
11. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233, 1991
12. Nagata S, Golstein P: The Fas death factor. Science 267:1449, 1995
13. Latinis KM, Carr LL, Peterson EJ, Norian LA, Eliason SL, Koretzky GA: Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events. J Immunol 158:4602, 1997
14. Ju ST, Panka DJ, Cui H, Ettinger R, el Khatib M, Sherr DH, Stanger BZ, Marshak Rothstein A: Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444, 1995
15. Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR: Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441, 1995
16. Lynch DH, Ramsdell F, Alderson MR: Fas and FasL in the homeostatic regulation of immune responses, Immunol Today 16:569, 1995
17. Hahn S, Gehri R, Erb P: Mechanism and biological significance of CD4-mediated cytotoxicity, Immunol Rev 146:57, 1995
18. Walker PR, Saas P, Dietrich PY: Role of Fas ligand (CD95L) in immune escape: The tumor cell strikes back. J Immunol 158:4521, 1997
19. Hahne M, Renno T, Schroeter M, Irmler M, French L, Bernard T, MacDonald HR, Tschopp J: Activated B cells express functional Fas ligand. Eur J Immunol 26:721, 1996
20. Villunger A, Egle A, Marschitz M, Kos M, Boeck G, Ludwig H, Geley S, Kofler R, Greil R: Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: A potential mechanism of tumor-induced suppression of immune surveillance. Blood 90:12, 1997
21. Saltman D, Bansal NS, Ross FM, Ross JA, Turner G, Guy K: Establishment of a karyotypically normal B-chronic lymphocytic leukemia cell line; evidence of leukemic origin by immunoglobulin gene rearrangement. Leuk Res 14:381, 1990
22. Strasser-Wozak E, Hattmannstorfer R, Hala M, Hartmann B, Fiegl M, Geley S, Kofler R: Splice site mutations in the glucocorticoid receptor gene causes resistance to GC-induced apoptosis in a human acute leukemia cell line. Cancer Res 55:348, 1995
23. Enari M, Hug H, Nagata S: Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375:78, 1995
24. Matzinger P: The JAM test. A simple assay for DNA fragmentation and cell death. J Immunol Methods 145:185, 1991
25. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, Green DR: Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182:1545, 1995
26. Yonehara S, Shii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747, 1989
27. Amadori A, Zamarchi R, De Silvestro G, Forza G, Cavatton G, Danieli GA, Clementi M, Chieco-Bianchi L: Genetic control of the CD4/CD8 T-cell ratio in humans. Nature Med 1:1279, 1995
28. Villunger A, Egle A, Kos M, Hartmann BL, Geley S, Kofler R, Greil R: Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells. Cancer Res 57:3331, 1997
29. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169, 1993
30. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM: FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing complex. Cell 85:817, 1996
31. Oyaizu N, McCloskey T, Than S, Hu R, Kalyanaraman VS, Pahwa S: Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-γ and tumor necrosis factor-α secretion. Blood 84:2622, 1994
32. Sieg S, Huang Y, Kaplan D: Viral regulation of CD95 expression and apoptosis in T-lymphocytes. J Immunol 159:1192, 1997
33. Amasaki Y, Kobayashi S, Takeda T, Ogura N, Jodo S, Nakabayashi T, Tsutsumi A, Fujiskaku A, Koike T: Up-regulated expression of Fas antigen (CD95) by peripheral naive and memory T-cell subsets in patients with systemic lupus erythematosus (SLE): A possible mechanism for lymphopenia. Clin Exp Immunol 99:245, 1995
34. di Celle PF, Carbone A, Marchis D, Zhou D, Sozzani S, Zupo S, Pini M, Mantovani A, Foa R: Cytokine gene expression in B-cell chronic lymphocytic leukemia: Evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein. Blood 84:220, 1994
35. Trentin L, Zambello R, Agostini C, Enthammer C, Cerutti A, Adami F, Zamboni S, Semenzato G: Expression and regulation of tumor necrosis factor, interleukin-2 and hematopoietic growth factor receptors in B-cell chronic lymphocytic leukemia. Blood 84:4249, 1994
36. Giordano C, Stassi G, De Maria R, Todaro M, Richiusa P, Papoff G, Ruberti G, Bagnasco M, Testi R, Galluzzo A: Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275:960, 1997
37. Alderson MR, Armitage RJ, Maraskovsky E, Tough TW, Roux E, Schooley K, Ramsdell F, Lynch DH: Fas transduced activation signals in normal human T-lymphocytes. J Exp Med 178:2231, 1993
38. Miyawaki T, Uehara T, Nibu R, Tsuji T, Yachie A, Yonehara S, Taniguchi N: Differential expression of apoptosis-related antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 149:3753, 1992
39. Rathmell JC, Townsend SE, Xu JC, Flavell RA, Goodnow CC: Expansion or elimination of B cells in vivo: Dual roles for CD-40 and Fas ligands modulated by the B-cell antigen receptor. Cell 87:319, 1996
40. Rothstein TL, Wang JK, Panka DJ, Foote LC, Wang Z, Stanger B, Cui H, Ju ST, Marshak Rothstein A: Protection against Fas-dependent Th 1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374:163, 1995
41. Foote LC, Howard RG, Marshak-Rothstein A, Rothstein TL: IL-4 induces Fas-resistance in B cells. J Immunol 157:2749, 1996
42. Hashimoto F, Oyaizu N, Kalyanaraman VS, Pahwa S: Modulation of Bcl-2 protein by CD4 cross-linking: A possible mechanism for lymphocyte apoptosis in human immunodeficiency virus infection and for rescue of apoptosis by interleukin-2. Blood 90:745, 1997